scholarly journals How often do women use non-drug treatment methods for psyschiatric symptoms during pregnancy and postpartum periods?

2019 ◽  
Vol 11 (1) ◽  
Author(s):  
Hilal Uslu Yuvaci ◽  
Esra Yazici ◽  
Ahmet Bulent Yazici ◽  
Serhan Cevrioglu
Keyword(s):  
Postpartum Period ◽  
Hypericum Perforatum ◽  
Bright Light ◽  
Light Treatment ◽  
Omega 3 ◽  
Pregnancy And Postpartum ◽  
Drug Treatments ◽  
Adenosyl Methionine ◽  
Passiflora Incarnata

The aim of this study was to determine the prevalence of complementary and alternative medical applications (CAM) and non-drug treatments of women during their pregnancies, postpartum periods and the changes between these periods. The Screening Form for Non-pharmacologic Methods Used during Pregnancy and Postpartum period was administered to the participants. Passiflora (Incarnata), Hypericum perforatum (St. John’s Wort), omega 3 supplements, bright light treatment, transmagnetic stimulation, S-adenosyl- methionine, herbal teas, biofeedback/neurofeedback, amulets, exercise, acupuncture and psychotherapy were investigated. The ratio of the use of one of the CAM methods for psychiatric complaints during people’s lifetime was found to be 33.3% (n=162). Herbal teas were the main practice used during pregnancy (58.8%) and the postpartum. The use of CAM according to the utilization periods of the participants statistically significantly decreased in those who were currently pregnant (Cochran’s Q=298.007; P<0.05). The use of participants’ non-drug treatments in the periodical follow-up decreased in those who are currently pregnant and increased during the postpartum period.

scholarly journals How often do women use non-drug treatment methods for psychiatric symptoms during pregnancy and postpartum periods?

2019 ◽  
Vol 11 (1) ◽  
pp. 13-17
Author(s):  
Hilal Uslu Yuvaci ◽  
Esra Yazici ◽  
Ahmet Bulent Yazici ◽  
Serhan Cevrioglu
Keyword(s):  
Postpartum Period ◽  
Hypericum Perforatum ◽  
Psychiatric Symptoms ◽  
Bright Light ◽  
Omega 3 ◽  
Pregnancy And Postpartum ◽  
Drug Treatments ◽  
Adenosyl Methionine ◽  
Passiflora Incarnata

The aim of this study was to determine the prevalence of complementary and alternative medical applications (CAM) and non-drug treatments of women during their pregnancies, postpartum periods and the changes between these periods. The Screening Form for Non-pharmacologic Methods Used during Pregnancy and Postpartum period was administered to the participants. Passiflora (Incarnata), Hypericum perforatum (St. John's Wort), omega 3 supplements, bright light treatment, transmagnetic stimulation, S-adenosyl-methionine, herbal teas, biofeedback/neurofeedback, amulets, exercise, acupuncture and psychotherapy were investigated. The ratio of the use of one of the CAM methods for psychiatric complaints during people's lifetime was found to be 33.3% (n=162). Herbal teas were the main practice used during pregnancy (58.8%) and the postpartum. The use of CAM according to the utilization periods of the participants statistically significantly decreased in those who were currently pregnant (Cochran's Q=298.007; P<0.05). The use of participants' non-drug treatments in the periodical follow-up decreased in those who are currently pregnant and increased during the postpartum period.

The depression in women in pregnancy and postpartum period: A follow-up study

2014 ◽  
Vol 61 (4) ◽  
pp. 343-349 ◽  
Author(s):  
Tulay Sati Kirkan ◽  
Nazan Aydin ◽  
Esra Yazici ◽  
Puren Akcali Aslan ◽  
Hamit Acemoglu ◽  
...  
Keyword(s):  
Postpartum Period ◽  
Follow Up Study ◽  
Pregnancy And Postpartum ◽  
In Pregnancy

scholarly journals Morning Bright Light Treatment for Chronic Low Back Pain: Potential Impact on the Volatility of Pain, Mood, Function, and Sleep

Pain Medicine ◽  
2019 ◽  
Vol 21 (6) ◽  
pp. 1153-1161
Author(s):  
John W Burns ◽  
James Gerhart ◽  
Muneer Rizvydeen ◽  
Momoko Kimura ◽  
Helen J Burgess
Keyword(s):  
Low Back Pain ◽  
Back Pain ◽  
Negative Affect ◽  
Pain Intensity ◽  
Chronic Low Back Pain ◽  
Bright Light ◽  
Light Treatment ◽  
Low Back ◽  
Bright Light Treatment

Abstract Objectives Most treatment outcome studies for people with chronic low back pain (CLBP) have based analyses on and reported only the mean levels of these factors. However, high levels of pain, mood, function, and sleep volatility may represent unique factors contributing to diminished quality of life. Our goal was to determine whether bright light treatment affected both mean levels of pain, mood, function, and sleep and reduced volatility in these outcomes. Methods US military veterans with CLBP (N = 22) underwent an open trial with a seven-day baseline, followed by 13 days of a one-hour morning bright light treatment self-administered at their home and a 30-day follow-up. Participants completed daily diary measures at 12 Pm and 6 Pm every day during the three study epochs. Results Using location scale modeling, results suggested that, in addition to being associated with changes in mean levels of pain intensity, pain interference, negative affect, and sleep quality, bright light treatment was also related to reductions in the volatility of pain intensity and negative affect, reductions that were largely maintained during follow-up. Conclusions Changes in mean levels and volatility were independent factors, suggesting that bright light treatment was related to participants experiencing fewer “pain flares.” These findings underscore the potential importance of volatility as a future treatment target.

Complementary Effects of Multivitamin and Omega-3 Fatty Acid Supplementation on Indices of Cardiovascular Health in Individuals with Elevated Homocysteine

2012 ◽  
Vol 82 (1) ◽  
pp. 41-52 ◽  
Author(s):  
P. Earnest ◽  
S. Kupper ◽  
M. Thompson ◽  
Guo ◽  
S. Church
Keyword(s):  
Risk Factors ◽  
Cardiovascular Health ◽  
Omega 3 Fatty Acids ◽  
Omega 3 ◽  
C Reactive Protein ◽  
Fatty Acid Supplementation ◽  
Omega 3 Fatty Acid ◽  
Reactive Protein ◽  
Daily Ingestion

Homocysteine (HCY), C-reactive protein (hsCRP), and triglycerides (TG) are risk factors for cardiovascular disease (CVD). While multivitamins (MVit) may reduce HCY and hsCRP, omega-3 fatty acids (N3) reduce TG; yet, they are seldom studied simultaneously. We randomly assigned 100 participants with baseline HCY (> 8.0 umol/L) to the daily ingestion of: (1) placebo, (2) MVit (VitC: 200 mg; VitE: 400 IU; VitB6: 25 mg; Folic Acid: 400 ug; VitB12: 400 ug) + placebo, (3) N3 (2 g N3, 760 mg EPA, 440 mg DHA)+placebo, or (4) MVit + N3 for 12 weeks. At follow-up, we observed significant reductions in HCY (umol/L) for the MVit (- 1.43, 95 %CI, - 2.39, - 0.47) and MVit + N3 groups (- 1.01, 95 %CI, - 1.98, - 0.04) groups, both being significant (p < 0.05) vs. placebo (- 0.57, 95 %CI, - 1.49, 0.35) and N3 (1.11, 95 % CI, 0.07, 2.17). hsCRP (nmol/L) was significantly reduced in the MVit (- 6.00, 95 %CI, - 1.04, - 0.15) and MVit + N3 (- 0.98, 95 %CI, - 1.51, - 0.46) groups, but not vs. placebo (- 0.15, 95 %CI, - 0.74, 0.43) or N3 (- 0.53, 95 %CI, - 1.18, 0.12). Lastly, we observed significant reductions in TG for the N3 (- 0.41, 95 %CI, - 0.69, - 0.13) and MVit + N3 (- 0.71, 95 %CI, - 0.93, - 0.46) groups, both significant vs. placebo (- 0.10, 95 %CI, - 0.36, 0.17) and MVit groups (0.15, 95 %CI, - 12, 0.42). The co-ingestion of MVit + N3 provides synergistic affects on HCY, hsCRP, and plasma TG.

scholarly journals Association of the Omega-3 Index with Incident Prostate Cancer with Updated Meta-Analysis: The Cooper Center Longitudinal Study

Nutrients ◽  
2021 ◽  
Vol 13 (2) ◽  
pp. 384
Author(s):  
Stephen W. Farrell ◽  
Laura F. DeFina ◽  
Nathan L. Tintle ◽  
David Leonard ◽  
Kenneth H. Cooper ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Proportional Hazards ◽  
Meta Analysis ◽  
Continuous Variable ◽  
Omega 3 ◽  
Proportional Hazards Regression ◽  
Time To Diagnosis ◽  
Docosahexaenoic Acids ◽  
Long Chain

Background: The association between long-chain omega-3 polyunsaturated fatty acids (n-3 PUFA) and prostate cancer (PC) remains unclear. Methods: We compared incident PC rates as a function of the Omega-3 Index [O3I, erythrocyte eicosapentaenoic and docosahexaenoic acids (EPA + DHA)] in 5607 men (40–80 years of age) seen at the Cooper Clinic who were free of PC at baseline. The average follow-up was 5.1 ± 2.8 years until censoring or reporting a new PC diagnosis. Proportional hazards regression was used to model the linear association between baseline O3I and the age-adjusted time to diagnosis. A meta-analysis of n-3 PUFA biomarker-based studies and incident PC was updated with the present findings. Results: A total of 116 cases of incident PC were identified. When O3I was examined as a continuous variable, the age-adjusted hazard ratio (HR) (95% CI) was 0.98 (0.89, 1.07; p = 0.25) for each 1% increment in the O3I. The updated meta-analysis with 10 biomarker-based studies found no significant relationship between EPA or DHA levels and risk for PC. Conclusions: We find no evidence in this study nor in a meta-analysis of similar studies that consuming n-3 PUFA-rich fish or using fish oil supplements affects the risk of PC.

737 Prediction of drop out in an adjunctive light treatment trial in patients with non-seasonal depression and evening chronotype

SLEEP ◽  
2021 ◽  
Vol 44 (Supplement_2) ◽  
pp. A287-A288
Author(s):  
Joey W Chan ◽  
Y K Wing ◽  
S P Lam ◽  
Shirley Xin Li ◽  
J Zhang
Keyword(s):  
Clinical Characteristics ◽  
Red Light ◽  
Bright Light ◽  
Fold Increase ◽  
Light Therapy ◽  
Light Treatment ◽  
Drop Out ◽  
Sleep Diary ◽  
Significant Difference ◽  
Seasonal Depression

Abstract Introduction Drop out during treatment hampers therapeutic effect of interventions. The current study examines the possible predictors of drop out during the five-week light treatment in patients with unipolar non-seasonal depression and evening-chronotype. Methods Baseline characteristics including demographics, sleep diary parameters, light treatment prescribed, and early clinical outcomes changes were compared between the Drop out and Non drop out group. Logistic regression analysis was used to examine predictors for drop out. All data were analyzed in a modified intention to treat analysis with last observation carried forward approach. Results A total of 91 subjects (Female 79%, 46.3 ± 11.8 years old) were included in the analysis. There was no significant difference in the baseline demographic and clinical characteristics between the Drop out and Non drop out group. There was also no significant difference in the improvement of clinical parameters over the first week among the two groups. However, treatment non-adherence (in terms of compliance of less than 80% of prescribed duration) over the first treatment week predicts a five-fold increase in risk of drop out during light therapy. (OR: 5.85, CI: 1.414–24.205, p=0.015) after controlling for potential confounders including age, gender, treatment group, patient expectation, and treatment-emergent adverse events. Conclusion This study found that baseline clinical characteristics including depression severity and improvement of depressive symptoms in the initial week did not differ between the Drop out and Non drop out group. The drop out was also not affected by the type of light (dim red versus bright red light), indirectly supporting dim red light as a valid placebo in bright light therapy trial. Treatment adherence is the early phase of light treatment is an important predictor of drop out. Support (if any):

Redox status and oxidative stress during late pregnancy and postpartum period in mares

2019 ◽  
Vol 230 ◽  
pp. 103821 ◽  
Author(s):  
Stefano Cecchini ◽  
Francesco Fazio ◽  
Marilena Bazzano ◽  
Anna Rocchina Caputo ◽  
Claudia Giannetto ◽  
...  
Keyword(s):  
Oxidative Stress ◽  
Postpartum Period ◽  
Late Pregnancy ◽  
Redox Status ◽  
Pregnancy And Postpartum ◽  
And Oxidative Stress

Liver Failure in a Dog Following Suspected Ingestion of Blue-Green Algae (Microcystis spp.): A Case Report and Review of the Toxin

2013 ◽  
Vol 49 (5) ◽  
pp. 342-346 ◽  
Author(s):  
Lionel Sebbag ◽  
Nicole Smee ◽  
Deon van der Merwe ◽  
Dustin Schmid
Keyword(s):  
Green Algae ◽  
Acute Hepatic Failure ◽  
Fresh Frozen Plasma ◽  
Blue Green Algae ◽  
Fresh Frozen ◽  
Adenosyl Methionine ◽  
B Complex Vitamins ◽  
Time Of Admission ◽  
Frozen Plasma

A 2.5 yr old spayed female Weimaraner presented after ingestion of blue-green algae (Microcystis spp.). One day prior to presentation, the patient was swimming at a local lake known to be contaminated with high levels of blue-green algae that was responsible for deaths of several other dogs the same summer. The patient presented 24 hr after exposure with vomiting, inappetence, weakness, and lethargy. Blood work at the time of admission was consistent with acute hepatic failure, characteristic findings of intoxication by Microcystis spp. Diagnosis was suspected by analyzing a water sample from the location where the patient was swimming. Supportive care including fluids, fresh frozen plasma, whole blood, vitamin K, B complex vitamins, S-adenosyl methionine, and Silybum marianum were started. The patient was discharged on supportive medications, and follow-up blood work showed continued improvement. Ingestion is typically fatal for most patients. This is the first canine to be reported in the literature to survive treatment after known exposure.

Sign in / Sign up

Export Citation Format

Share Document